Candidate predictor | Women with early onset pre-eclampsia n = 954 Mean (SD) or n (%) | Number of women with missing data n (%) |
---|---|---|
Maternal characteristics | ||
 Maternal age (years), mean (SD) | 30.2 (6.1) | 2 (0.2%) |
 Gestational age at diagnosis (weeks), mean (SD) | 30.5 (2.9) | – |
 Number of fetuses in pregnancya |  |  |
  Singleton | 866 (91%) |  |
  Twins | 83 (9%) | – |
  Triplets | 5 (1%) |  |
 Parity |  | – |
  0 | 551 (58%) |  |
  1 | 207 (22%) |  |
  2 | 109 (11%) |  |
  3 | 55 (6%) |  |
  4 | 20 (2%) |  |
  5 – 9 | 12 (1%) |  |
History | ||
 Medical historyb |  | 1 (0.1%) |
  None | 601 (63%) |  |
  At least one condition | 251 (26%) |  |
  Two or more conditions | 101 (11%) |  |
  Chronic hypertension | 139 (15%) | 10 (1.0%) |
  Renal disease | 30 (3%) | 10 (1.0%) |
  Previous history of pre-eclampsia | 169 (43%) | 558b |
  Autoimmune disease | 18 (2%) | 32 (3.4%) |
  Diabetes mellitus | 109 (11%) | 6 (0.6%) |
Symptoms | ||
 Symptoms of headache and/or visual disturbance | 382 (41%) | 28 (2.9%) |
 Symptoms of epigastric pain, nausea and/or vomiting | 202 (22%) | 47 (4.9%) |
 Symptoms of chest pain and/or breathlessness | 60 (7%) | 126 (13.2%) |
Bedside examination and tests | ||
 Systolic blood pressure (mmHg), mean (SD) | 159 (19) | 5 (0.5%) |
 Diastolic blood pressure (mmHg), mean (SD) | 99 (12) | 5 (0.5%) |
 Clonus | 95 (17%) | 403 (42.2%) |
 Exaggerated tendon reflexes | 147 (24%) | 353 (37%) |
 Oxygen saturation by pulse oximetry (%), mean (SD) | 98 (2) | 521 (54.6%) |
 Oxygen saturation: abnormal (< 94%) | 4 (1%) | 521 (54.6%) |
Urine dipstick | Â | Â |
  None/Trace | 39 (4%) |  |
  1+ | 170 (18%) |  |
  2+ | 314 (34%) | 19 (2%) |
  3+ | 306 (33%) |  |
   ≥ 4 | 106 (11%) |  |
Laboratory tests | ||
 Haemoglobin (g/L), mean (SD) | 11.9 (1.3) | 37 (3.9%) |
 Platelet count (× 109/L), mean (SD) | 226 (78) | 41 (4.3%) |
 Alanine transaminase (U/L), mean (SD) | 31.0 (71.0) | 75 (7.9%) |
 Serum uric acid (μmol/L), mean (SD) | 0.6 (2.7) | 165 (17.3%) |
 Serum urea (mmol/L), mean (SD) | 4.6 (4.4) | 70 (7.3%) |
 Serum creatinine (μmol/L), mean (SD) | 61.0 (17.8) | 38 (4%) |
 Urine PCR (mg/mmol), mean (SD) | 273 (492) | 109 (11.4%) |
Treatment provided | ||
 Any anti-hypertensive therapyc | 753 (79%) | 6 (0.6%) |
 Oral anti-hypertensive therapy | 734 (77%) | 6 (0.6%) |
 Parenteral anti-hypertensive therapy | 111 (12%) | 6 (0.6%) |
 Parenteral magnesium sulfated | 144 (15%) | 6 (0.6%) |